Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00384683 · ClinicalTrials.gov registry record
Endothelial Dysfunction As A Predictor Of Perioperative Outcome
A clinical trial, sponsored by M.D. Anderson Cancer Center.
- Completed
- Registry status
- 90
- Enrollment target
NCT00384683: Completed study, sponsored by M.D. Anderson Cancer Center.
NCT00384683 is a clinical trial that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00384683 has completed, sponsored by M.D. Anderson Cancer Center.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
The goal of this clinical research study is to learn whether the inability of certain blood vessel cells (endothelial cells) to function properly may help researchers to predict who is at risk for complications after surgery and whether this dysfunction contributes to complications after surgery. This study will use a blood test to quantify the number of cells that are destined to become endothelial cells.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2006-03 |
| Est. Completion | 2019-06-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00384683
The ClinicalTrials.gov registry entry for NCT00384683 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00384683 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00384683 about?
NCT00384683 is a clinical study titled "Endothelial Dysfunction As A Predictor Of Perioperative Outcome". The goal of this clinical research study is to learn whether the inability of certain blood vessel cells (endothelial cells) to function properly may help researchers to predict who is at risk for complications after surgery and whether this dysfunction contributes to complications after surgery. Th...
What is the current status of trial NCT00384683?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2006-03. Estimated completion is 2019-06-05.
Who is sponsoring clinical trial NCT00384683?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.